Share of global biopharmaceutical pipeline (snapshot)
Proportion of global biopharmaceutical research and development pipeline assets originating from a specific country or region.
Unit Percent Industry Pharmaceuticals
The chart
The figure
One published observation so far. A chart follows as soon as a second period is published.
Every record
All records
1 record · 1 region · 2026
| Period | Value | Source | Type |
|---|---|---|---|
| China 1 record | |||
| as of 30 Jun 2026 | 30% | NHSA · 30 Jun 2026 | actual |
Primary documents
Sources
1 document. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| 国家医疗保障局 医保动态 我国上半年创新药对外授权交易额超千亿美元 | NHSA | — | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Share of global biopharmaceutical pipeline (snapshot). Retrieved from https://statorigin.org/indicators/share-of-global-biopharmaceutical-pipeline-snapshot